Whole saliva specimens from eight healthy human adults were examined for neuraminidase. The presence of two types of neuraminidase in four samples out of eight was demonstrated by means of polyacrylamide gel electrophoresis and sucrose density gradient centrifugation. One type is soluble and the other an insoluble, perhaps particle-bound, enzyme. The pH optima were 5.8 for the former and 5.0 to 5.3 for the latter. However, the soluble enzyme could not be detected in the other four saliva specimens which showed low activity. A comparative study of the salivary and other neuraminidases was carried out. It was found that both salivary neuraminidases were closely similar to the enzymes in submandibular-sublingual secretions and in human liver, but not to the oral streptococcal enzymes. The results suggest that the salivary neuraminidases might originate from cells such as epithelial cells or polymorphonuclear leukocytes, or both, in the oral cavity.
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Neuraminidase activity (EC 3.2.1.18; Nacetylneuraminate glycohydrolase) has been demonstrated in human whole saliva and submandibular-sublingual secretions (10, (14) (15) (16) 20) . Moreover, it has been suggested that the enzyme may play a role in plaque formation and periodontal disease (9, 12) . However, a significant difference in neuraminidase activity has not been demonstrated among clinically different groups (17) .
It has been found that some microorganisms from the oral flora produce the enzyme in culture media (7, 18, 19, 22) . Therefore, the oral bacteria would seem to be the prime source of salivary neuraminidase. However, cellular components in whole saliva, such as leukocytes and epithelial cells, also have been suggested as another possible source of the enzyme (16) . The elucidation of the source of salivary neuraminidase is important for a better understanding of the role of the enzyme in periodontal disease. Thus, the present studies were undertaken to characterize salivary neuraminidase by means of polyacrylamide gel electrophoresis and sucrose density gradient centrifugation, and then to compare salivary neuraminidases and those obtained from Streptococcus mitis, Streptococcus sanguis, and human liver.
MATERIALS AND METHODS
Collection and concentration of saliva. Twentyfive to 50 ml each of unstimulated whole saliva was collected, in chilled beakers, from healthy human adults, 20 to 50 years old. The viscosity of the saliva was reduced by a Waring blender running at top speed for 15 s. Each homogenized saliva specimen was centrifuged at 14,500 x g for 30 min. To the supernatant fluids was added ammonium sulfate up to 70% saturation. The resulting precipitates were suspended in a small volume of 0.01 M phosphate buffer, pH 6.5, and dialyzed against the same buffer. The final volume of the concentrated saliva was adjusted to 0.5 ml. The submandibular-sublingual secretions were collected by means of a modified Lashley cannula (6) into chilled vessels, and parotid saliva was obtained by using vacuum caps (4) .
Enzyme assay. The standard assay procedure for neuraminidase activity was described in preceding articles (7, 13 (23) .
Polyacrylamide gel electrophoresis. Polyacrylamide gels at pH 8.7 were prepared by a modified method originally described by Davis (5) . These gels routinely contained 7.5% acrylamide. A 10-to 50-Mg sample of protein mixed with a drop of glycerol and 0.0002% bromophenol blue tracking dye was applied directly to the gel. For the determination of neuraminidase activity in the gel, unstained gels were sliced at 5-mm widths. Each sliced gel was homogenized by a Teflon homogenizer in 0.6 ml of distilled water and put in the reaction mixture for the enzyme assay.
Determination of pH optimum. After fractionation of the concentrated saliva by polyacrylamide gel electrophoresis, a gel was checked for zones of enzymatic activity as described above, and the corresponding regions were cut out from unstained gels. Slices from five such gels were combined, homogenized in an equal volume of distilled water and divided into six test tubes for the enzyme assay. The fractions obtained by the density gradient centrifugation also were used for determination of the pH optimum of the enzyme.
Protein determination. The method of Lowry (11) was used with crystalline bovine serum albumin as a standard.
RESULTS
Electrophoretic patterns of the neuraminidase activity in saliva. Neuraminidase activity in whole saliva from eight persons is recorded in Table 1 . In order to determine the basis of the differences shown between the high and low levels, each concentrated saliva specimen was subjected to polyacrylamide gel electrophoresis. Figures la and b show the locations of the enzyme activity in the gels. There are two major peaks of neuraminidase activity in the whole saliva of sample 2 which showed higher activity ( Fig. la) : the activity was located at two fractions (0-5 mm and 25-30 mm). On the other hand, in the whole saliva of sample 6, which showed lower activity, one of these activities was not detected (Fig. lb) . The results are summarized in Table 2 . The two types of neuraminidase were detected in four samples out of eight, whereas one of the two neuraminidases was not detected in the others.
Fractionation by density gradient centrifugation. The whole saliva specimens were subjected to density gradient centrifugation. The neuraminidase activity in samples 1 to 4 was detected at the top layer and at the interface of 1.06 to 1.155 density, whereas in samples 5 to 8 none was detected at the top layer (Fig. 2) . It was confirmed that the enzyme at the top layer corresponded to the one migrating into the gel, and the other enzyme at the 1.06 to 1.155 density interface corresponded to the one which remained on top of the gel. The results indicate that the saliva samples 1 to 4 contained two types of neuraminidase, in soluble and insoluble forms, whereas the saliva samples 5 to 8 contained a single type of neuraminidase, in the insoluble form only.
pH activity curves. pH activity curves for both enzymes are shown in Fig. 3 . It can be seen from the curves that the soluble enzyme showed optimum activity at pH 5.8 and the insoluble enzyme at pH 5.0 to 5.3.
Comparison with salivary and other neuraminidases. Neuraminidase preparations obtained from S. mitis and S. sanguis were subjected to polyacrylamide gel electrophoresis. Both neuraminidases were located in the same fraction (15 to 20 mm) (Fib. 4b). However, the mobility seemed to be different from the mobilities of the salivary neuraminidases. To confirm this finding, the concentrated saliva and streptococcal enzyme preparations were combined and subjected to electrophoresis. Three peaks of the enzyme activity were detected: the first was located at the top of the gel, (Fig. 4c) . Recovery of the activity in each fraction was almost the same irrespective as to whether salivary and streptococcal neuraminidases were run separately or together. The first and third peaks were located in the same fractions as the two salivary neuraminidases (Fig. 4a) . Therefore, it seemed that these two activities were due to the two salivary neuraminidases. The second activity was located at the same position where the streptococcal neuraminidase was found (Fig.  4b) (Fig. 4d) . From the results it was clear that both salivary enzymes behaved differently than the streptococcal enzyme and similarly to both human liver neuraminidases.
The homogenates of human liver and the supernatant fluids of disrupted bacterial cells were subjected to density gradient centrifugation. The neuraminidase activities of the liver were detected at the top layer and at the two interfaces, 1.06 to 1.155 and 1.155 to 1.21. On the other hand, the bacterial enzyme was detected only at the top layer ( Table 3) .
The pH optima of the salivary neuraminidases were compared with those of the bacterial and the human liver enzymes, since both salivary neuraminidases might be distinguished from the bacterial enzymes, although not from both human liver enzymes, with respect to pH optima. The pH optimum of neuraminidase of S. mitis ATCC 9811 was 6.1, as described in the preceding paper (7) , and the enzymes of S. sanguis ATCC 10557 and of strain of S. sanguis also showed optimum activity at 6.1. Further, the pH optimum of the human liver enzymes was 5.8 for the soluble and 5.0 for the insoluble preparations (Table 4) .
Neuraminidase activity in submandibularsublingual secretions. Neuraminidase activity was detected in submandibular-sublingual secretions from those persons whose whole saliva showed higher activity but not from those subjects with lower activity. Separation of neuraminidase in concentrated secretions was carried out by polyacrylamide gel electrophoresis and density gradient centrifugation. It was found that the submandibular-sublingual secre- CTulsiani and Carubelli (23) . tions also contained the two types of the neuraminidases which had the same mobility, molecular size, and pH optima as the neuraminidases in whole saliva. Data on the specific activity of neuraminidases in whole saliva and submandibular-sublingual secretions are shown in Table 5 . The specific activity of neuraminidase in submandibular-sublingual secretions was less than 10% of that of the whole saliva.
Neuraminidase activity was found in the homogenates of human gingiva but the activity was too low to be estimated.
DISCUSSION
The presence of two types of neuraminidase in four out of eight samples of human whole saliva has been demonstrated using polyacrylamide gel electrophoresis and density gradient centrifugation, whereas only one of the two enzymes was detected in the other samples which showed lower activity. We assume that whole saliva from healthy adults may contain two types of neuraminidase, one of these, the soluble enzyme, sometimes being too low in activity to be detected. However, the reasons for these differences are obscure. The two salivary enzymes revealed marked differences with respect to mobility on electrophoresis, molecular size on density gradient centrifugation, and pH optimum. However, at the present stage of our studies it is difficult to rule out the possibility that one of the enzymes, the insoluble macromolecular enzyme, might be an aggregate of the soluble form. Tulsiani and Carubelli (23) reported that rat mammary glands contained a soluble neuraminidase in the cytosol and a particulate neuraminidase strongly bound to the lysosomes. Schengrund, Jensen, and Rosenberg (21) have presented evidence that neuraminidase is localized in the plasma membrane of rat liver cells. Therefore, it is possible that the insoluble enzyme in whole saliva might be a particulate enzyme which is bound to the plasma membranes or the lysosomes released from destroyed cells in the oral cavity. Perlitsh and Glickman (15) have demonstrated that the optimum pH for neuraminidase in whole saliva extended over the range of 5.5 to 6.5. Accordingly, the enzyme assay for the homogenized slices of the gel was carried out at pH 6.0 and 6.5, but no other activity in addition to the two neuraminidases was demonstrated in whole saliva.
For comparative studies, only four neuraminidase preparations from two strains of S. mitis and two strains of S. sanguis were studied. There may be other oral bacteria producing the enzyme. However, this appears unlikely to be the case for the following reasons: our previous paper (7) reported that some strains of S. mitis and S. sanguis produce neuraminidase in culture, but the activity was not detected with a number of other oral bacteria tested. Pinter, Hayashi, and Bahn (19) reported that some cariogenic streptococci produced the enzyme, and Burnett and Scherp (1) reported that streptococci account for a large part of the bacterial flora in saliva. Moreover, our results indicate that the two salivary neuraminidases are closely related to the human liver neuraminidases, but not to the bacterial enzymes. Submandibular-sublingual secretions which are not contaminated with bacteria contained enzymes resembling the two salivary enzymes. Recently, we have found that salivary immunoglobulin A inhibits bacterial neuraminidases and other enzymes, but not salivary neuraminidase. From these results it may be concluded that bacterial neuraminidase may contribute little to the activity of saliva. It is improbable that most of the activity found in whole saliva was derived from submandibular-sublingual glands, because a very low specific activity was demonstrated in the secretions, as shown in Table 2 . Moreover, the activity was not detected in the parotid secretion. The results strongly suggest that most of the enzymes in whole saliva are derived from cells such as leukocytes or epithelial cells in the oral cavity, rather than from the major salivary glands. However it is difficult to rule out the possibility that the minor salivary glands are another source of the neuraminidases. Extension of these studies undoubtedly will lead to a more precise understanding of the physiological and pathological roles of neuraminidase in the oral cavity.
